FocusDiagnostics

Does molecular monitoring matter in early-stage breast cancer?

Science Translational Medicine  26 Aug 2015:
Vol. 7, Issue 302, pp. 302fs35
DOI: 10.1126/scitranslmed.aac9445

You are currently viewing the abstract.

View Full Text

Abstract

Serial monitoring of circulating tumor DNA predicts recurrence after treatment for localized breast cancer (Garcia-Murillas et al., this issue).

View Full Text